Thompson, R., & Eastman, A. (2013). The cancer therapeutic potential of Chk1 inhibitors: How mechanistic studies impact on clinical trial design. Blackwell Science Inc.
Παραπομπή Chicago StyleThompson, Ruth, και Alan Eastman. The Cancer Therapeutic Potential of Chk1 Inhibitors: How Mechanistic Studies Impact On Clinical Trial Design. Blackwell Science Inc, 2013.
Παραπομπή MLAThompson, Ruth, και Alan Eastman. The Cancer Therapeutic Potential of Chk1 Inhibitors: How Mechanistic Studies Impact On Clinical Trial Design. Blackwell Science Inc, 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.